Mesenchymal Stem Cells for Frailty Syndrome

NCT06501066 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
66
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Meribank Biotech Co., Ltd.